Stock Information
Incyte Corp (INCY)
Ticker Symbol: INCY
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $22,725.22 mil
Piotroski score: 6
PE Ratio: 16.066
EPS (TTM): 7.0731
Revenue (TTM): $25.92 M
Dividend Yield: N/A%
ROE: 29.2%
Latest News
-
INCY Stock Hits 52-Week High on Regulatory Updates for Opzelura
Mon, Jun 29, 2026 5:39 PM
-
Incyte (INCY) Surges 5.8%: Is This an Indication of Further Gains?
Mon, Jun 29, 2026 1:54 PM
-
1 Cash-Producing Stock with Solid Fundamentals and 2 We Turn Down
Mon, Jun 29, 2026 10:10 AM
-
Hormuz Goes Quiet, Software Wakes Up, and Burry Picks a Side
Mon, Jun 29, 2026 9:45 AM
-
Incyte: New Catalysts Support Another Leg Higher
Mon, Jun 29, 2026 8:35 AM
-
HC Wainwright & Co. Reiterates Buy on Incyte, Maintains $140 Price Target
Mon, Jun 29, 2026 6:15 AM
-
Incyte (INCY) Stock After 66% One-Year Rally Is The Market Too Optimistic Now
Sat, Jun 27, 2026 3:07 PM
-
Incyte (INCY) Wins EU Backing For Opzelura As Pipeline Data Builds Across Four Drugs
Sat, Jun 27, 2026 6:06 AM
-
Lilly, J&J and AbbVie Hit New Highs
Fri, Jun 26, 2026 5:49 PM
-
UBS Maintains Neutral on Incyte, Raises Price Target to $113
Fri, Jun 26, 2026 2:25 PM
Key Financials
Financial data not available
